Skip to main content

Table 3 Subgroup analysis results of PLR and ovarian cancer survival (OS and PFS)

From: Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review

Subgroup Analysis Univariate analysis Heterogeneity P1 value Multivariate analysis Heterogeneity P2 value
NO. ES (95% CI) NO. ES (95% CI)
PLR for OS 6 2.53 (2.16-2.96) 0.001 6 1.97 (1.61-2.40) 0.824
Subgroup 1: cut-off
 >  200 4 2.63 (2.23-3.10) 0.002 4 2.06 (1.16-2.56) 0.867
 ≤ 200 2 1.86 (1.15-3.01) 0.74 2 1.47 (0.87-2.48) 0.770
Supgroup 2: sample size
 >  200 2 2.82 (2.31-3.45) 0.000 2 2.02 (1.54-2.65) 0.422
 ≤ 200 4 2.14 (1.67-2.75) 0.193 4 1.91 (1.42-2.55) 0.694
 PLR for PFS 5 2.48 (2.10-2.92) 0.000 5 1.79 (1.46-2.20) 0.810
Subgroup 1: cut-off
 >  200 3 2.75 (2.28-3.31) 0.001 3 1.89 (1.50-2.38) 0.943
 ≤ 200 2 1.70 (1.19-2.42) 0.354 2 1.41 (0.88-2.66) 0.606
Supgroup 2: sample size
 >  200 1 3.85 (2.96-5.01) / 1 1.95 (1.43-2.66) /
 ≤ 200 4 1.86 (1.51-2.30) 0.330 4 1.67 (1.27-2.20) 0.788